Neglected Tropical Diseases in Clinical Research

The Pharmaceutical research and development has historically neglected the infectious diseases that mainly or exclusively affect poor communities generally in low or middle income countries. Recently, collaborative clinical research addressing health needs of these low and middle income countries has become more frequent regarding therapeutic and diagnostic trials for neglected tropical diseases and is often conducted by non-commercial groups. The Good Clinical Practices codes (GCP) standardized by WHO provide global applicable standards for design, conduct, record, and reporting clinical trials. The Good Clinical Laboratory Practices (GCLP) codes are set by United Nations Development, World Bank, and WHO for Research and Training in Tropical Diseases. There are various challenges that need to be overcome for the improved diagnostics and management of the neglected tropical diseases.

  • Binary Thinking and Syndromic Management of NTDS
  • Implementing Research Compliant with Good Clinical Practice (GCP)
  • Good Clinical Laboratory Practice (GCLP)
  • Maintaining Improved Patient Care after Clinical Studies Have Come to an End

 

  • Binary Thinking and Syndromic Management
  • Good Clinical Practice (GCP)
  • Good clinical laboratory practice (GCLP)
  • Improved Patient Care
  • Binary thinking

Related Conference of Neglected Tropical Diseases in Clinical Research

Neglected Tropical Diseases in Clinical Research Conference Speakers